» Articles » PMID: 24931095

The Magnetic Resonance Imaging-linac System

Overview
Specialties Oncology
Radiology
Date 2014 Jun 17
PMID 24931095
Citations 158
Authors
Affiliations
Soon will be listed here.
Abstract

The current image-guided radiotherapy systems are suboptimal in the esophagus, pancreas, kidney, rectum, lymph node, etc. These locations in the body are not easily accessible for fiducials and cannot be visualized sufficiently on cone-beam computed tomographies, making daily patient set-up prone to geometrical uncertainties and hinder dose optimization. Additional interfraction and intrafraction uncertainties for those locations arise from motion with breathing and organ filling. To allow real-time imaging of all patient tumor locations at the actual treatment position a fully integrated 1.5-T, diagnostic quality, magnetic resonance imaging with a 6-MV linear accelerator is presented. This system must enable detailed dose painting at all body locations.

Citing Articles

Institutionalisation of convergent medical innovation: an empirical study of the MRI-guided linear accelerator in the Netherlands and the United States.

Hehakaya C, Moors E Innovation (North Syd). 2025; 27(1):74-95.

PMID: 39935856 PMC: 11809769. DOI: 10.1080/14479338.2023.2213212.


Feasibility and time gain of implementing artificial intelligence-based delineation tools in daily magnetic resonance image-guided adaptive prostate cancer radiotherapy.

Konrad M, Brink C, Bertelsen A, Lorenzen E, Celik B, Nyborg C Phys Imaging Radiat Oncol. 2025; 33:100694.

PMID: 39885904 PMC: 11780162. DOI: 10.1016/j.phro.2024.100694.


MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer.

Allegra A, Nicosia L, Rigo M, Bianchi N, Borgese R, Simone A Technol Cancer Res Treat. 2025; 24:15330338241297231.

PMID: 39865869 PMC: 11770696. DOI: 10.1177/15330338241297231.


Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapy.

Subashi E, LoCastro E, Burleson S, Apte A, Zelefsky M, Tyagi N Phys Imaging Radiat Oncol. 2024; 32():100678.

PMID: 39717186 PMC: 11665667. DOI: 10.1016/j.phro.2024.100678.


Assessing intra- and interfraction motion and its dosimetric impacts on cervical cancer adaptive radiotherapy based on 1.5T MR-Linac.

Wang H, Li Z, Shi D, Yin P, Liang B, Zou J Radiat Oncol. 2024; 19(1):176.

PMID: 39696365 PMC: 11653819. DOI: 10.1186/s13014-024-02569-5.